“…Nimesulide belongs to the class-II biopharmaceutical classification drug with a low solubility and high permeability [17,18]. Nimesulide is a weak inhibitor of prostaglandin synthesis in vitro and it appears to show its effects by a variety of mechanisms like free-radical scavenging, involving in neutrophil myeloperoxidase pathway, phosphodiesterase type IV inhibition, histamine release, tumor necrosis factor-alpha release, cartilage degradation, bradykinin activity, metaloprotease synthesis, platelet aggregation, and synthesis of platelet activity factor [19,20] used the Nimesulide in control drug delivery [21,22]. Nimesulide produces gastric irritation in some cases and shows loss of its inhibitory cyclooxygenase-2 (COX-2) selectivity [23,24].…”